Li et al. found that miR-181a-2-3p level was notably elevated in human gastric cancer cell lines, facilitated the progression of gastric cancer cell by targeting MYLK, which may be a pivotal prognostic biomarker for gastric cancer33, targeting oncogenic miR-181a-2-3p inhibits growth and suppresses cisplatin resistance of gastric cancer34. The gene discussed is MYLK; the disease is gastric cancer.